On November 12, health authorities in Ethiopia heightened investigations and emergency response measures after eight suspected cases of viral hemorrhagic fever (VHF) were reported in the South Ethiopia Region. Ongoing laboratory testing at the Ethiopia Public Health Institute has confirmed six cases of Marburg Virus Disease (MVD), with three fatalities. Additionally, three probable cases have been identified among deceased individuals. A total of 206 contacts related to the cases have been identified and are under active monitoring. The source of the infection remains unknown, marking the first confirmed outbreak of MVD in the country.
The World Health Organization (WHO) deployed a team of 11 technical officers to support increased disease surveillance, case investigation, laboratory diagnostics, and infection control measures. WHO is also providing essential medical supplies, including personal protective equipment for health workers, and has mobilized US$300,000 in emergency funds to bolster the response efforts. These resources aim to prepare Ethiopia for managing the outbreak while further investigations are conducted.
- Why it matters: The outbreak underscores the importance of rapid response in limiting the spread of infectious diseases, which can have severe public health implications. Businesses may need to consider continuity plans in light of health emergencies.
- This situation could lead to increased international collaboration in health responses, impacting global health security strategies.
- The latest: WHO continues to monitor the situation and has committed additional technical support as needed to manage the evolving outbreak.
Source: https://www.contagionlive.com/view/ethiopia-investigates-marburg-virus-disease-outbreak
Source: https://www.contagionlive.com/view/ethiopia-investigates-marburg-virus-disease-outbreak